Cartesian Therapeutics, Inc. - COM NEW (RNAC)

Historical Portfolio Holders from Q1 2023 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
3.05M
Holdings value Q2 2024
$82.3M
Value change Q2 2024
+$82.1M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
55
Number of buys Q2 2024
0
Number of sells Q2 2024
-2
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 48.6K $724K -$255K $16.09 9
2024 Q2 3.05M $82.3M +$82.1M $27.01 55
2024 Q1 1.86K $1.16K +$1.16K $0.64 4
2023 Q4 0 $0 -$1.27K 0
2023 Q3 1.2K $1.27K $0 $1.06 1
2023 Q2 1.2K $1.34K $0 $1.12 1
2023 Q1 1.2K $1.67K $0 $1.39 1